Abstract
Transcarotid arterial revascularization (TCAR) has been associated with a lower risk of stroke or death compared with transfemoral carotid artery stenting (TFAS) and a lower risk of cranial nerve injury and myocardial infarction than carotid endarterectomy (CEA). To the best of our knowledge, no comparative studies have been performed of the costs between TCAR, CEA, and TFAS, which could have important implications on institutional support for the new modality to address carotid artery stenosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
